Spatially Fractionated Radiotherapy With Tislelizumab and Chemotherapy for Bulky Stage III NSCLC: A Phase II Trial
Clinical trial NCT07775040 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07775040
- Sponsor
- Sichuan Cancer Hospital and Research Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-20
- Primary completion
- 2030-06-30
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.